Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-08

Clinical Trial Update: Cholecalciferol on Depressive Symptoms in Type 2 Diabetes Mellitus Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring cholecalciferol (vitamin D3) for depressive symptoms in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Indonesia University | Conditions: Diabetes Mellitus, Type 2, Depressive Symptoms | Phase 2 | Status: UNKNOWN